180 related articles for article (PubMed ID: 37805878)
1. MANAGEMENT OF RISKS OF ADVERSE DRUG REACTIONS ACCORDING TO ADR REPORT FORM DATA FROM LVIV REGION HEALTHCARE FACILITIES IN 2022.
Stepaniuk N; Piniazhko O; Poshyvak O; Bessarab T; Hudz N; Gavriluk I
Georgian Med News; 2023; (340-341):76-80. PubMed ID: 37805878
[TBL] [Abstract][Full Text] [Related]
2. Combination angiotensin-receptor blocker (ARB)/calcium channel blocker with HCTZ vs the maximal recommended dose of an ARB with HCTZ in patients with stage 2 hypertension: the exforge as compared to losartan treatment in stage 2 systolic hypertension (EXALT) study.
Wright RF; Duprez D; Purkayastha D; Samuel R; Ferdinand KC
J Clin Hypertens (Greenwich); 2011 Aug; 13(8):588-97. PubMed ID: 21806769
[TBL] [Abstract][Full Text] [Related]
3. Role of valsartan, amlodipine and hydrochlorothiazide fixed combination in blood pressure control: an update.
Destro M; Cagnoni F; D'Ospina A; Ricci AR; Demichele E; Peros E; Zaninelli A; Preti P
Vasc Health Risk Manag; 2010 Apr; 6():253-60. PubMed ID: 20407632
[TBL] [Abstract][Full Text] [Related]
4. Valsartan, a new angiotensin II receptor antagonist: a double-blind study comparing the incidence of cough with lisinopril and hydrochlorothiazide.
Benz J; Oshrain C; Henry D; Avery C; Chiang YT; Gatlin M
J Clin Pharmacol; 1997 Feb; 37(2):101-7. PubMed ID: 9055135
[TBL] [Abstract][Full Text] [Related]
5. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I
Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
[TBL] [Abstract][Full Text] [Related]
6. Comparison of real-world adherence, healthcare resource utilization and costs for newly initiated valsartan/amlodipine single-pill combination versus angiotensin receptor blocker/calcium channel blocker free-combination therapy.
Baser O; Andrews LM; Wang L; Xie L
J Med Econ; 2011; 14(5):576-83. PubMed ID: 21728914
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the efficacy and safety profiles of two fixed-dose combinations of antihypertensive agents, amlodipine/benazepril versus valsartan/hydrochlorothiazide, in patients with type 2 diabetes mellitus and hypertension: a 16-week, multicenter, randomized, double-blind, noninferiority study.
Lee IT; Hung YJ; Chen JF; Wang CY; Lee WJ; Sheu WH
Clin Ther; 2012 Aug; 34(8):1735-50. PubMed ID: 22784975
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of fixed-dose combination therapy in the treatment of patients with hypertension: focus on amlodipine/valsartan.
da Silva PM
Clin Drug Investig; 2010; 30(9):625-41. PubMed ID: 20626210
[TBL] [Abstract][Full Text] [Related]
9. A noninferiority comparison of valsartan/hydrochlorothiazide combination versus amlodipine in black hypertensives.
Weir MR; Ferdinand KC; Flack JM; Jamerson KA; Daley W; Zelenkofske S
Hypertension; 2005 Sep; 46(3):508-13. PubMed ID: 16116046
[TBL] [Abstract][Full Text] [Related]
10. Triple combination therapy with amlodipine, valsartan, and hydrochlorothiazide vs dual combination therapy with amlodipine and hydrochlorothiazide for stage 2 hypertensive patients.
Destro M; Crikelair N; Yen J; Glazer R
Vasc Health Risk Manag; 2010 Sep; 6():821-7. PubMed ID: 20859551
[TBL] [Abstract][Full Text] [Related]
11. Amlodipine/valsartan single-pill combination: a review of its use in the management of hypertension.
Frampton JE; Scott LJ
Am J Cardiovasc Drugs; 2009; 9(5):309-30. PubMed ID: 19791840
[TBL] [Abstract][Full Text] [Related]
12. Randomized study to compare valsartan +/- HCTZ versus amlodipine +/- HCTZ strategies to maximize blood pressure control.
Zappe D; Papst CC; Ferber P;
Vasc Health Risk Manag; 2009; 5():883-92. PubMed ID: 19898644
[TBL] [Abstract][Full Text] [Related]
13. Real-world effectiveness of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in high-risk patients and other subgroups.
Assaad-Khalil SH; Najem R; Sison J; Kitchlew AR; Cho B; Ueng KC; DiTommaso S; Shete A
Vasc Health Risk Manag; 2015; 11():71-8. PubMed ID: 25653536
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of single-pill combination in uncontrolled essential hypertension: A systematic review and network meta-analysis.
Xie M; Tang T; Liang H
Clin Cardiol; 2023 Aug; 46(8):886-898. PubMed ID: 37432701
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
[TBL] [Abstract][Full Text] [Related]
16. A randomized, double-blind, active-controlled, parallel-group comparison of valsartan and amlodipine in the treatment of isolated systolic hypertension in elderly patients: the Val-Syst study.
Malacco E; Varì N; Capuano V; Spagnuolo V; Borgnino C; Palatini P;
Clin Ther; 2003 Nov; 25(11):2765-80. PubMed ID: 14693303
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin receptor blocker/diuretic combination preserves insulin responses in obese hypertensives.
Sowers JR; Raij L; Jialal I; Egan BM; Ofili EO; Samuel R; Zappe DH; Purkayastha D; Deedwania PC
J Hypertens; 2010 Aug; 28(8):1761-9. PubMed ID: 20498618
[TBL] [Abstract][Full Text] [Related]
18. Prospective and randomized study of the antihypertensive effect and tolerability of three antihypertensive agents, losartan, amlodipine, and lisinopril, in hypertensive patients.
Wu SC; Liu CP; Chiang HT; Lin SL
Heart Vessels; 2004 Jan; 19(1):13-8. PubMed ID: 14685749
[TBL] [Abstract][Full Text] [Related]
19. Combination of amlodipine 10 mg and valsartan 160 mg lowers blood pressure in patients with hypertension not controlled by an ACE inhibitor/CCB combination.
Trenkwalder P; Schaetzl R; Borbas E; Handrock R; Klebs S
Blood Press Suppl; 2008 Dec; 2():13-21. PubMed ID: 19205092
[TBL] [Abstract][Full Text] [Related]
20. Role of combination therapy in the treatment of hypertension: focus on valsartan plus amlodipine.
Ferri C; Croce G; Desideri G
Adv Ther; 2008 Apr; 25(4):300-20. PubMed ID: 18449492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
